Dongguan Trial Medical Co., Ltd. is a specialized manufacturer of remote clinical trial monitoring devices, decentralized clinical trial solutions, and digital research technologies. Established in 2016, the company is located in Dongguan, China, a major center for advanced manufacturing, medical technology development, and electronic innovation.
Operating from a modern facility covering more than 11,000 square meters, with a team of over 230 employees, Trial Medical is dedicated to developing and manufacturing innovative technologies that support clinical research organizations, pharmaceutical companies, healthcare institutions, and academic research centers worldwide.
The company's product portfolio includes remote clinical trial monitoring devices, wearable health data collection systems, patient engagement platforms, electronic clinical outcome assessment solutions, digital research tools, remote safety monitoring systems, and decentralized trial support technologies. These solutions are designed to facilitate real-time data collection, improve participant engagement, streamline study management, and enhance operational efficiency throughout the clinical research process.
Supported by an experienced team of engineers, software developers, and quality management professionals, Trial Medical continuously invests in research and development to address the evolving needs of modern clinical studies. The company integrates advanced connectivity technologies, cloud-based data management capabilities, and intelligent monitoring functions to support reliable and scalable clinical research operations.
Transitioning from traditional site-based models to virtual environments. Our platforms enable hybrid and fully remote study designs, reducing patient burden and increasing recruitment rates across diverse demographics.
Leveraging IoT-enabled medical peripherals to capture continuous physiological data. From vital signs monitoring to activity tracking, we provide researchers with granular "Information Gain" that traditional clinical visits miss.
End-to-end encryption and blockchain-ready auditing trails. We ensure that every data point—from patient wearable to researcher dashboard—is compliant with 21 CFR Part 11 and GDPR standards.
Our platforms now utilize edge computing and AI algorithms to filter "noise" from wearable sensor data, ensuring only high-quality, actionable clinical signals reach the study investigators.
Moving beyond monitoring to prevention. We are developing predictive modules that alert CROs to potential patient safety risks before they manifest clinically, using historical data and real-time biometric trends.
The goal is a seamless ecosystem where "Trial Telehealth" becomes an invisible layer of healthcare. Multi-vendor device support and automated EHR integration will become the standard.
Comprehensive quality control procedures are implemented across product design, manufacturing, testing, and inspection processes to ensure consistent performance and product reliability. Serving customers across North America, Europe, Asia-Pacific, the Middle East, Latin America, and Africa, Dongguan Trial Medical Co., Ltd. is committed to advancing digital clinical research.